A public offering of common stock and stock purchase warrants has pulled in $10 million for Gaithersburg, Md.-based OpGen. The proceeds will be used as working capital, as well as to support other general corporate functions, including the development of the company's rapid antibiotic resistance diagnostic product.
Public offering brings in $10M for OpGen
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.